SmartScripts
Cheapest Consultsmartscripts.ie
Cheapest consultation. Online-only service. Irish-based.
- Consult
- €20
- Mounjaro
- €300-€475/mo
- Wegovy
- Available
Ozempic is licensed for diabetes. Here is what weight-loss searchers usually need to check instead.
Ozempic is licensed for diabetes, not weight management
The semaglutide medication licensed for weight management is Wegovy — same active ingredient, different dose range and licence.
Ozempic is the brand name for semaglutide, a medication developed by Novo Nordisk and approved for the treatment of type 2 diabetes in adults. It works by mimicking the GLP-1 hormone, which stimulates insulin production, reduces glucagon secretion, and slows gastric emptying — resulting in better blood sugar control and, as a side effect, reduced appetite.
In clinical trials for diabetes, patients taking Ozempic also lost significant amounts of weight. This effect attracted enormous media attention — particularly in the United States — which led many people to search for Ozempic specifically when they actually wanted a weight loss medication.
In Ireland, medicines are regulated through licensed indications. Ozempic is licensed for the treatment of type 2 diabetes. It is not the product licensed for chronic weight management.
This is not because semaglutide does not work for weight loss. It clearly does. The issue is one of regulatory licencing: Novo Nordisk developed a separate product — Wegovy — with a specific weight loss licence, a higher dose (2.4mg vs 2mg weekly), and clinical trials focused on obesity management rather than diabetes control.
Prescribers should follow licensed indications, clinical guidance and individual patient suitability. If you are looking for semaglutide for weight management, ask about Wegovy rather than trying to source Ozempic.
If you are in Ireland and searching for Ozempic for weight loss, what you actually need is Wegovy. Here is why they are often confused:
Wegovy became available in Ireland in March 2025 and is now accessible via several online providers without needing a GP referral.
| Feature | Ozempic | Wegovy (what you want) |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Maximum dose | 2mg weekly | 2.4mg weekly |
| Licensed use in Ireland | Type 2 diabetes only | Weight management |
| Available for weight loss? | No | Yes |
| Average weight loss | ~10–12% | ~15% |
| Monthly cost (Ireland) | N/A (diabetes patients only) | €220+ |
| Available online in Ireland? | No | Yes — multiple providers |
Getting Wegovy in Ireland is straightforward. You do not need a GP referral. Several regulated online providers offer an initial medical consultation followed by a prescription and delivery to your door. The process typically takes 24–72 hours from consultation to first delivery.
To be eligible, you generally need:
All providers listed below are regulated, offer online consultations, and can deliver Wegovy throughout Ireland.
smartscripts.ie
Cheapest consultation. Online-only service. Irish-based.
healthhero.ie
Ireland-based GP-led weight-management pathway. Public page states prescriptions are sent to Republic of Ireland pharmacies only.
zavamed.com/ie
Pan-European digital health provider. Strong patient support.
my-bmi.ie
Most established Irish weight loss clinic. Coaching included.
lloydsonlinedoctor.ie
Trusted pharmacy brand. Prescription service with pharmacist support.
beyondbmi.ie
Premium medically-led programme. GP-supervised treatment.
weightlossinjections.ie
Injectable-focused route. Public FAQ describes Republic of Ireland and Northern Ireland pharmacy fulfilment.
Ozempic is licensed for type 2 diabetes, not weight management. If you are researching semaglutide for weight loss, ask a clinician about licensed weight-management options such as Wegovy and whether they are suitable for you.
Both contain semaglutide, but at different doses and with different licences. Ozempic is approved for type 2 diabetes (up to 2mg weekly). Wegovy is approved for chronic weight management (up to 2.4mg weekly). Wegovy's higher dose produces greater weight loss results.
Yes. Wegovy became available in Ireland in March 2025 via private prescription. Several online providers now offer it, with monthly costs starting around €220.
Ozempic became widely known through media coverage of its weight loss effects — particularly from high-profile users abroad. However, the weight loss version of the same drug (semaglutide) sold in Ireland is Wegovy, not Ozempic.
No. As Ozempic is not licenced for weight loss in Ireland, prescribing it for that purpose would be off-label and is not standard practice. Your GP can, however, refer you for Wegovy or recommend an online weight loss programme.
Clinical trials suggest Mounjaro (tirzepatide) produces greater average weight loss than Wegovy — up to 22% versus around 15%. However, Mounjaro typically costs more and works through a dual mechanism (GIP + GLP-1). Both are available in Ireland via private prescription.
Compare all Irish providers and find the Wegovy plan that suits you.
Compare Providers